{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:13:38Z","timestamp":1761581618487,"version":"3.37.3"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T00:00:00Z","timestamp":1508976000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s40263-017-0473-5","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T09:31:38Z","timestamp":1509010298000},"page":"975-989","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pharmacotherapy of Cardiovascular Autonomic Dysfunction in Parkinson Disease"],"prefix":"10.1007","volume":"31","author":[{"given":"Cyndya A.","family":"Shibao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1851-9981","authenticated-orcid":false,"given":"Horacio","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,26]]},"reference":[{"issue":"12","key":"473_CR1","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257\u201372.","journal-title":"Lancet Neurol."},{"issue":"3","key":"473_CR2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000275491","volume":"34","author":"A Wright Willis","year":"2010","unstructured":"Wright Willis A, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 2010;34(3):143\u201351.","journal-title":"Neuroepidemiology."},{"issue":"Pt 5","key":"473_CR3","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ. Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain. 1991;114(Pt 5):2283\u2013301.","journal-title":"Brain"},{"issue":"5","key":"473_CR4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ana.22284","volume":"69","author":"R Fuente-Fernandez de la","year":"2011","unstructured":"de la Fuente-Fernandez R, Schulzer M, Kuramoto L, Cragg J, Ramachandiran N, Au WL, et al. Age-specific progression of nigrostriatal dysfunction in Parkinson\u2019s disease. Ann Neurol. 2011;69(5):803\u201310.","journal-title":"Ann Neurol"},{"issue":"20","key":"473_CR5","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.wnl.0000312279.49272.9f","volume":"70","author":"H Braak","year":"2008","unstructured":"Braak H, Del Tredici K. Invited article: nervous system pathology in sporadic Parkinson disease. Neurology. 2008;70(20):1916\u201325.","journal-title":"Neurology."},{"issue":"2","key":"473_CR6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211.","journal-title":"Neurobiol Aging."},{"issue":"Pt 11","key":"473_CR7","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/brain\/awm056","volume":"130","author":"BF Boeve","year":"2007","unstructured":"Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. 2007;130(Pt 11):2770\u201388.","journal-title":"Brain."},{"issue":"5","key":"473_CR8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/mds.25445","volume":"28","author":"RB Postuma","year":"2013","unstructured":"Postuma RB, Gagnon JF, Pelletier A, Montplaisir J. Prodromal autonomic symptoms and signs in Parkinson\u2019s disease and dementia with Lewy bodies. Mov Disord. 2013;28(5):597\u2013604.","journal-title":"Mov Disord"},{"issue":"2","key":"473_CR9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ana.24877","volume":"81","author":"H Kaufmann","year":"2017","unstructured":"Kaufmann H, Norcliffe-Kaufmann L, Palma JA, Biaggioni I, Low PA, Singer W, et al. Natural history of pure autonomic failure: a United States prospective cohort. Ann Neurol. 2017;81(2):287\u201397.","journal-title":"Ann Neurol"},{"issue":"10","key":"473_CR10","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.parkreldis.2011.04.016","volume":"17","author":"DC Velseboer","year":"2011","unstructured":"Velseboer DC, de Haan RJ, Wieling W, Goldstein DS, de Bie RM. Prevalence of orthostatic hypotension in Parkinson\u2019s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2011;17(10):724\u20139.","journal-title":"Parkinsonism Relat Disord."},{"issue":"8","key":"473_CR11","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00415-016-8375-x","volume":"64","author":"CH Gibbons","year":"2017","unstructured":"Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;64(8):1567\u201382.","journal-title":"J Neurol."},{"issue":"5","key":"473_CR12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/mds.26079","volume":"30","author":"JA Palma","year":"2015","unstructured":"Palma JA, Gomez-Esteban JC, Norcliffe-Kaufmann L, Martinez J, Tijero B, Berganzo K, et al. Orthostatic hypotension in Parkinson disease: how much you fall or how low you go? Mov Disord. 2015;30(5):639\u201345.","journal-title":"Mov Disord"},{"issue":"8","key":"473_CR13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.parkreldis.2011.05.020","volume":"17","author":"AD Ha","year":"2011","unstructured":"Ha AD, Brown CH, York MK, Jankovic J. The prevalence of symptomatic orthostatic hypotension in patients with Parkinson\u2019s disease and atypical parkinsonism. Parkinsonism Relat Disord. 2011;17(8):625\u20138.","journal-title":"Parkinsonism Relat Disord."},{"issue":"2","key":"473_CR14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mds.20324","volume":"20","author":"MA Hely","year":"2005","unstructured":"Hely MA, Morris JG, Reid WG, Trafficante R. Sydney Multicenter Study of Parkinson\u2019s disease: non-l-dopa-responsive problems dominate at 15\u00a0years. Mov Disord. 2005;20(2):190\u20139.","journal-title":"Mov Disord"},{"issue":"5","key":"473_CR15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/heartjnl-2013-304121","volume":"100","author":"W Xin","year":"2014","unstructured":"Xin W, Lin Z, Mi S. Orthostatic hypotension and mortality risk: a meta-analysis of cohort studies. Heart. 2014;100(5):406\u201313.","journal-title":"Heart"},{"issue":"9","key":"473_CR16","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/mds.20571","volume":"20","author":"A Pathak","year":"2005","unstructured":"Pathak A, Lapeyre-Mestre M, Montastruc JL, Senard JM. Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure. Mov Disord. 2005;20(9):1213\u20139.","journal-title":"Mov Disord"},{"issue":"1","key":"473_CR17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00415-004-0276-8","volume":"251","author":"H Stolze","year":"2004","unstructured":"Stolze H, Klebe S, Zechlin C, Baecker C, Friege L, Deuschl G. Falls in frequent neurological diseases\u2013prevalence, risk factors and aetiology. J Neurol. 2004;251(1):79\u201384.","journal-title":"J Neurol"},{"issue":"9","key":"473_CR18","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/mds.20485","volume":"20","author":"H Woodford","year":"2005","unstructured":"Woodford H, Walker R. Emergency hospital admissions in idiopathic Parkinson\u2019s disease. Mov Disord. 2005;20(9):1104\u20138.","journal-title":"Mov Disord"},{"issue":"5","key":"473_CR19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.parkreldis.2015.01.017","volume":"21","author":"V Low","year":"2015","unstructured":"Low V, Ben-Shlomo Y, Coward E, Fletcher S, Walker R, Clarke CE. Measuring the burden and mortality of hospitalisation in Parkinson\u2019s disease: a cross-sectional analysis of the English Hospital Episodes Statistics database 2009\u20132013. Parkinsonism Relat Disord. 2015;21(5):449\u201354.","journal-title":"Parkinsonism Relat Disord."},{"key":"473_CR20","first-page":"906274","volume":"2013","author":"NE Allen","year":"2013","unstructured":"Allen NE, Schwarzel AK, Canning CG. Recurrent falls in Parkinson\u2019s disease: a systematic review. Parkinsons Dis. 2013;2013:906274.","journal-title":"Parkinsons Dis."},{"issue":"5","key":"473_CR21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/13696998.2017.1284668","volume":"20","author":"C Francois","year":"2017","unstructured":"Francois C, Biaggioni I, Shibao C, Ogbonnaya A, Shih HC, Farrelly E, et al. Fall-related healthcare use and costs in neurogenic orthostatic hypotension with Parkinson\u2019s disease. J Med Econ. 2017;20(5):525\u201332.","journal-title":"J Med Econ."},{"issue":"1","key":"473_CR22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.parkreldis.2005.06.011","volume":"12","author":"A Schrag","year":"2006","unstructured":"Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Caregiver-burden in parkinson\u2019s disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord. 2006;12(1):35\u201341.","journal-title":"Parkinsonism Relat Disord."},{"issue":"2","key":"473_CR23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s10286-005-0253-z","volume":"15","author":"C Magerkurth","year":"2005","unstructured":"Magerkurth C, Schnitzer R, Braune S. Symptoms of autonomic failure in Parkinson\u2019s disease: prevalence and impact on daily life. Clin Auton Res. 2005;15(2):76\u201382.","journal-title":"Clin Auton Res."},{"issue":"1","key":"473_CR24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00415-012-6627-y","volume":"260","author":"M Pilleri","year":"2013","unstructured":"Pilleri M, Facchini S, Gasparoli E, Biundo R, Bernardi L, Marchetti M, et al. Cognitive and MRI correlates of orthostatic hypotension in Parkinson\u2019s disease. J Neurol. 2013;260(1):253\u20139.","journal-title":"J Neurol"},{"issue":"8","key":"473_CR25","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/gps.1562","volume":"21","author":"LM Allcock","year":"2006","unstructured":"Allcock LM, Kenny RA, Mosimann UP, Tordoff S, Wesnes KA, Hildreth AJ, et al. Orthostatic hypotension in Parkinson\u2019s disease: association with cognitive decline? Int J Geriatr Psychiatry. 2006;21(8):778\u201383.","journal-title":"Int J Geriatr Psychiatry."},{"issue":"1","key":"473_CR26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/jgs.12592","volume":"62","author":"J Frewen","year":"2014","unstructured":"Frewen J, Savva GM, Boyle G, Finucane C, Kenny RA. Cognitive performance in orthostatic hypotension: findings from a nationally representative sample. J Am Geriatr Soc. 2014;62(1):117\u201322.","journal-title":"J Am Geriatr Soc"},{"issue":"1\u20132","key":"473_CR27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2010.08.056","volume":"299","author":"S Mehrabian","year":"2010","unstructured":"Mehrabian S, Duron E, Labouree F, Rollot F, Bune A, Traykov L, et al. Relationship between orthostatic hypotension and cognitive impairment in the elderly. J Neurol Sci. 2010;299(1\u20132):45\u20138.","journal-title":"J Neurol Sci"},{"issue":"2","key":"473_CR28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10072-011-0746-6","volume":"33","author":"R Poda","year":"2012","unstructured":"Poda R, Guaraldi P, Solieri L, Calandra-Buonaura G, Marano G, Gallassi R, et al. Standing worsens cognitive functions in patients with neurogenic orthostatic hypotension. Neurol Sci. 2012;33(2):469\u201373.","journal-title":"Neurol Sci."},{"issue":"1","key":"473_CR29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1212\/WNL.0000000000003452","volume":"88","author":"J Centi","year":"2017","unstructured":"Centi J, Freeman R, Gibbons CH, Neargarder S, Canova AO, Cronin-Golomb A. Effects of orthostatic hypotension on cognition in Parkinson disease. Neurology. 2017;88(1):17\u201324.","journal-title":"Neurology."},{"issue":"2","key":"473_CR30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ana.10236","volume":"52","author":"ST Li","year":"2002","unstructured":"Li ST, Dendi R, Holmes C, Goldstein DS. Progressive loss of cardiac sympathetic innervation in Parkinson\u2019s disease. Ann Neurol. 2002;52(2):220\u20133.","journal-title":"Ann Neurol."},{"issue":"1\u20132","key":"473_CR31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jns.2005.11.034","volume":"243","author":"J Mitsui","year":"2006","unstructured":"Mitsui J, Saito Y, Momose T, Shimizu J, Arai N, Shibahara J, et al. Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease. J Neurol Sci. 2006;243(1\u20132):101\u20134.","journal-title":"J Neurol Sci."},{"issue":"5","key":"473_CR32","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/WNL.53.5.1020","volume":"53","author":"S Braune","year":"1999","unstructured":"Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH. Cardiac uptake of [123I]MIBG separates Parkinson\u2019s disease from multiple system atrophy. Neurology. 1999;53(5):1020\u20135.","journal-title":"Neurology."},{"key":"473_CR33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/B978-0-444-53491-0.00021-3","volume":"117","author":"H Kaufmann","year":"2013","unstructured":"Kaufmann H, Goldstein DS. Autonomic dysfunction in Parkinson disease. Handb Clin Neurol. 2013;117:259\u201378.","journal-title":"Handb Clin Neurol."},{"issue":"Pt 3","key":"473_CR34","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/brain\/awm302","volume":"131","author":"S Orimo","year":"2008","unstructured":"Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, et al. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson\u2019s disease. Brain. 2008;131(Pt 3):642\u201350.","journal-title":"Brain"},{"issue":"Suppl 1","key":"473_CR35","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/S1353-8020(13)70024-5","volume":"20","author":"JA Palma","year":"2014","unstructured":"Palma JA, Kaufmann H. Autonomic disorders predicting Parkinson\u2019s disease. Parkinsonism Relat Disord. 2014;20(Suppl 1):S94\u20138.","journal-title":"Parkinsonism Relat Disord."},{"issue":"6","key":"473_CR36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02292766","volume":"11","author":"S Braune","year":"2001","unstructured":"Braune S. The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clin Auton Res. 2001;11(6):351\u20135.","journal-title":"Clin Auton Res"},{"issue":"3","key":"473_CR37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s10286-004-0188-9","volume":"14","author":"A Diedrich","year":"2004","unstructured":"Diedrich A, Biaggioni I. Segmental orthostatic fluid shifts. Clin Auton Res. 2004;14(3):146\u20137.","journal-title":"Clin Auton Res."},{"issue":"1","key":"473_CR38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/01.STR.29.1.104","volume":"29","author":"V Novak","year":"1998","unstructured":"Novak V, Novak P, Spies JM, Low PA. Autoregulation of cerebral blood flow in orthostatic hypotension. Stroke. 1998;29(1):104\u201311.","journal-title":"Stroke"},{"issue":"347","key":"473_CR39","doi-asserted-by":"crossref","first-page":"f6320","DOI":"10.1136\/bmj.f6320","volume":"05","author":"ST Bird","year":"2013","unstructured":"Bird ST, Delaney JA, Brophy JM, Etminan M, Skeldon SC, Hartzema AG. Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40\u201385 years in the United States: risk window analyses using between and within patient methodology. BMJ. 2013;05(347):f6320.","journal-title":"BMJ"},{"issue":"7","key":"473_CR40","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jacc.2006.06.052","volume":"48","author":"C Podoleanu","year":"2006","unstructured":"Podoleanu C, Maggi R, Brignole M, Croci F, Incze A, Solano A, et al. Lower limb and abdominal compression bandages prevent progressive orthostatic hypotension in elderly persons: a randomized single-blind controlled study. J Am Coll Cardiol. 2006;48(7):1425\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"473_CR41","first-page":"167","volume":"14","author":"AA Smit","year":"2004","unstructured":"Smit AA, Wieling W, Fujimura J, Denq JC, Opfer-Gehrking TL, Akarriou M, et al. Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction. Clin Auton Res. 2004;14(3):167\u201375.","journal-title":"Clin Auton Res."},{"issue":"9154","key":"473_CR42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(99)99015-3","volume":"353","author":"J Jordan","year":"1999","unstructured":"Jordan J, Shannon JR, Grogan E, Biaggioni I, Robertson D. A potent pressor response elicited by drinking water. Lancet. 1999;353(9154):723.","journal-title":"Lancet."},{"issue":"1","key":"473_CR43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11906-005-0050-z","volume":"7","author":"J Jordan","year":"2005","unstructured":"Jordan J. Effect of water drinking on sympathetic nervous activity and blood pressure. Curr Hypertens Rep. 2005;7(1):17\u201320.","journal-title":"Curr Hypertens Rep"},{"issue":"144","key":"473_CR44","first-page":"89","volume":"1992","author":"AD Harkel Ten","year":"1992","unstructured":"Ten Harkel AD, Baisch F, Karenmaker JM. Increased orthostatic blood pressure variability after prolonged head-down tilt. Acta Physiol Scand. 1992;1992(144):89\u201399.","journal-title":"Acta Physiol Scand."},{"issue":"1","key":"473_CR45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02291388","volume":"10","author":"JJ Lieshout van","year":"2000","unstructured":"van Lieshout JJ, Ten Harkel AD, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clin Auton Res. 2000;10(1):35\u201342.","journal-title":"Clin Auton Res."},{"issue":"2","key":"473_CR46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF02291232","volume":"6","author":"S Puvi-Rajasingham","year":"1996","unstructured":"Puvi-Rajasingham S, Mathias CJ. Effect of meal size on post-prandial blood pressure and on postural hypotension in primary autonomic failure. Clin Auton Res. 1996;6(2):111\u20134.","journal-title":"Clin Auton Res."},{"issue":"5","key":"473_CR47","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/01.HYP.18.5.694","volume":"18","author":"CJ Mathias","year":"1991","unstructured":"Mathias CJ. Postprandial hypotension. Pathophysiological mechanisms and clinical implications in different disorders. Hypertension. 1991;18(5):694\u2013704.","journal-title":"Hypertension."},{"issue":"5","key":"473_CR48","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1079\/BJN20051401","volume":"93","author":"R Visvanathan","year":"2005","unstructured":"Visvanathan R, Chen R, Garcia M, Horowitz M, Chapman I. The effects of drinks made from simple sugars on blood pressure in healthy older people. Br J Nutr. 2005;93(5):575\u20139.","journal-title":"Br J Nutr."},{"issue":"313","key":"473_CR49","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJM198508293130905","volume":"1985","author":"J Onrot","year":"1985","unstructured":"Onrot J, Goldberg MR, Biaggioni I, Hollister AS, Kincaid D, Robertson D. Hemodynamic and humoral effects of caffeine in human autonomic failure. NEnglJMed. 1985;1985(313):549\u201354.","journal-title":"NEnglJMed."},{"issue":"6","key":"473_CR50","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/mds.870120608","volume":"12","author":"KR Chaudhuri","year":"1997","unstructured":"Chaudhuri KR, Ellis C, Love-Jones S, Thomaides T, Clift S, Mathias CJ, et al. Postprandial hypotension and parkinsonian state in Parkinson\u2019s disease. Mov Disord. 1997;12(6):877\u201384.","journal-title":"Mov Disord"},{"issue":"8","key":"473_CR51","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1586\/14779072.2015.1057504","volume":"13","author":"H Kaufmann","year":"2015","unstructured":"Kaufmann H, Norcliffe-Kaufmann L, Palma JA. Droxidopa in neurogenic orthostatic hypotension. Expert Rev Cardiovasc Ther. 2015;13(8):875\u201391.","journal-title":"Expert Rev Cardiovasc Ther."},{"issue":"1","key":"473_CR52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/HYPERTENSIONAHA.114.04035","volume":"65","author":"I Biaggioni","year":"2015","unstructured":"Biaggioni I, Freeman R, Mathias CJ, Low P, Hewitt LA, Kaufmann H, et al. Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa. Hypertension. 2015;65(1):101\u20137.","journal-title":"Hypertension"},{"issue":"5","key":"473_CR53","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/mds.26086","volume":"30","author":"RA Hauser","year":"2015","unstructured":"Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson\u2019s disease (nOH306B). Mov Disord. 2015;30(5):646\u201354.","journal-title":"Mov Disord"},{"issue":"19","key":"473_CR54","doi-asserted-by":"crossref","first-page":"191802","DOI":"10.1103\/PhysRevLett.112.191802","volume":"112","author":"S Chatrchyan","year":"2014","unstructured":"Chatrchyan S, Khachatryan V, Sirunyan AM, Tumasyan A, Adam W, Bergauer T, et al. Measurement of inclusive W and Z boson production cross sections in pp collisions at sqrt[s]\u00a0=\u00a08 TeV. Phys Rev Lett. 2014;112(19):191802.","journal-title":"Phys Rev Lett"},{"issue":"4","key":"473_CR55","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","volume":"83","author":"H Kaufmann","year":"2014","unstructured":"Kaufmann H, Freeman R, Biaggioni I, Low P, Pedder S, Hewitt LA, et al. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology. 2014;83(4):328\u201335.","journal-title":"Neurology."},{"issue":"1","key":"473_CR56","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12883-017-0867-5","volume":"17","author":"I Biaggioni","year":"2017","unstructured":"Biaggioni I, Arthur Hewitt L, Rowse GJ, Kaufmann H. Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension. BMC Neurol. 2017;17(1):90.","journal-title":"BMC Neurol."},{"issue":"5","key":"473_CR57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/WNF.0000000000000168","volume":"39","author":"RA Hauser","year":"2016","unstructured":"Hauser RA, Heritier S, Rowse GJ, Hewitt LA, Isaacson SH. Droxidopa and reduced falls in a trial of parkinson disease patients with neurogenic orthostatic hypotension. Clin Neuropharmacol. 2016;39(5):220\u20136.","journal-title":"Clin Neuropharmacol."},{"issue":"5","key":"473_CR58","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/01.HYP.5.5.772","volume":"1983","author":"MR Goldberg","year":"1983","unstructured":"Goldberg MR, Hollister AS, Robertson D. Influence of yohimbine on blood pressure, autonomic reflexes and plasma catecholamines in humans. Hypertension. 1983;1983(5):772\u20138.","journal-title":"Hypertension"},{"issue":"37","key":"473_CR59","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1212\/WNL.37.2.215","volume":"1987","author":"J Onrot","year":"1987","unstructured":"Onrot J, Goldberg MR, Biaggioni I, Wiley R, Hollister AS, Robertson D. Oral yohimbine in human autonomic failure. Neurology. 1987;1987(37):215\u201320.","journal-title":"Neurology."},{"issue":"2","key":"473_CR60","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0002-9343(98)00193-4","volume":"105","author":"J Jordan","year":"1998","unstructured":"Jordan J, Shannon JR, Biaggioni I, Norman R, Black BK, Robertson D. Contrasting actions of pressor agents in severe autonomic failure. Am J Med. 1998;105(2):116\u201324.","journal-title":"Am J Med."},{"issue":"5","key":"473_CR61","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/HYPERTENSIONAHA.110.154898","volume":"56","author":"C Shibao","year":"2010","unstructured":"Shibao C, Okamoto LE, Gamboa A, Yu C, Diedrich A, Raj SR, et al. Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. 2010;56(5):847\u201351.","journal-title":"Hypertension"},{"issue":"9","key":"473_CR62","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/jnnp.74.9.1294","volume":"74","author":"W Singer","year":"2003","unstructured":"Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2003;74(9):1294\u20138.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"4","key":"473_CR63","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archneur.63.4.noc50340","volume":"63","author":"W Singer","year":"2006","unstructured":"Singer W, Sandroni P, Opfer-Gehrking TL, Suarez GA, Klein CM, Hines S, et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol. 2006;63(4):513\u20138.","journal-title":"Arch Neurol"},{"issue":"2","key":"473_CR64","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2165\/00003495-200464020-00005","volume":"64","author":"D Simpson","year":"2004","unstructured":"Simpson D, Plosker GL. Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder. Drugs. 2004;64(2):205\u201322.","journal-title":"Drugs."},{"issue":"1","key":"473_CR65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/HYPERTENSIONAHA.107.089961","volume":"50","author":"C Shibao","year":"2007","unstructured":"Shibao C, Raj SR, Gamboa A, Diedrich A, Choi L, Black BK, et al. Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function. Hypertension. 2007;50(1):47\u201353.","journal-title":"Hypertension."},{"issue":"6","key":"473_CR66","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1161\/HYPERTENSIONAHA.114.04225","volume":"64","author":"CE Ramirez","year":"2014","unstructured":"Ramirez CE, Okamoto LE, Arnold AC, Gamboa A, Diedrich A, Choi L, et al. Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. 2014;64(6):1235\u201340.","journal-title":"Hypertension"},{"issue":"13","key":"473_CR67","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.1997.03540370036033","volume":"277","author":"PA Low","year":"1997","unstructured":"Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. Jama. 1997;277(13):1046\u201351.","journal-title":"Jama."},{"issue":"1","key":"473_CR68","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/WNL.51.1.120","volume":"51","author":"RA Wright","year":"1998","unstructured":"Wright RA, Kaufmann HC, Perera R, Opfer-Gehrking TL, McElligott MA, Sheng KN, et al. A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology. 1998;51(1):120\u20134.","journal-title":"Neurology."},{"issue":"196","key":"473_CR69","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.0954-6820.1974.tb01044.x","volume":"1974","author":"S Bevegard","year":"1974","unstructured":"Bevegard S, Castenfors J, Lindblad LE. Haemodynamic effects of dihydroergotamine in patients with postural hypotension. Acta Med Scand. 1974;1974(196):473\u20137.","journal-title":"Acta Med Scand."},{"issue":"92","key":"473_CR70","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-92-3-387","volume":"1980","author":"NL Benowitz","year":"1980","unstructured":"Benowitz NL, Byrd R, Schambelan M, Rosenberg J, Roizen MF. Dihydroergotamine treatment for orthostatic hypotension from Vacor rodenticide. Ann Int Med. 1980;1980(92):387\u20138.","journal-title":"Ann Int Med."},{"issue":"67","key":"473_CR71","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/01.CIR.67.3.602","volume":"1983","author":"AV Chobanian","year":"1983","unstructured":"Chobanian AV, Tifft CP, Faxon DP, Creager MLA, Sackel H. Treatment of orthostatic hypotension with ergotamine. Circulation. 1983;1983(67):602\u20139.","journal-title":"Circulation"},{"issue":"105","key":"473_CR72","doi-asserted-by":"crossref","first-page":"168","DOI":"10.7326\/0003-4819-105-2-168","volume":"1986","author":"RD Hoeldtke","year":"1986","unstructured":"Hoeldtke RD, Cavanaugh ST, Hughes JD, Polansky M. Treatment of orthostatic hypotension with dihydroergotamine and caffeine. Ann Int Med. 1986;1986(105):168\u201373.","journal-title":"Ann Int Med."},{"issue":"65","key":"473_CR73","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0002-9149(90)90031-U","volume":"1990","author":"I Biaggioni","year":"1990","unstructured":"Biaggioni I, Zygmunt D, Haile V, Robertson D. Pressor effect of inhaled ergotamine in orthostatic hypotension. Am J Cardiol. 1990;1990(65):89\u201392.","journal-title":"Am J Cardiol"},{"key":"473_CR74","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fphys.2014.00270","volume":"5","author":"AC Arnold","year":"2014","unstructured":"Arnold AC, Ramirez CE, Choi L, Okamoto LE, Gamboa A, Diedrich A, et al. Combination ergotamine and caffeine improves seated blood pressure and presyncopal symptoms in autonomic failure. Front Physiol. 2014;5:270.","journal-title":"Front Physiol."},{"issue":"2","key":"473_CR75","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01826210","volume":"1","author":"E Armstrong","year":"1991","unstructured":"Armstrong E, Mathias CJ. The effects of the somatostatin analogue, octreotide, on postural hypotension, before and after food ingestion, in primary autonomic failure. Clin Auton Res. 1991;1(2):135\u201340.","journal-title":"Clin Auton Res."},{"issue":"2","key":"473_CR76","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0140-6736(86)92428-1","volume":"1986","author":"RD Hoeldtke","year":"1986","unstructured":"Hoeldtke RD, O\u2019Dorisio TM, Boden G. Treatment of autonomic neuropathy with a somatostatin analog SMS 201-995. Lancet. 1986;1986(2):602\u20135.","journal-title":"Lancet"},{"issue":"86","key":"473_CR77","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0002-9343(89)90442-7","volume":"1989","author":"RD Hoeldtke","year":"1989","unstructured":"Hoeldtke RD, Dworkin GE, Gaspar SR, Israel BC, Boden G. Effect of the somatostatin analogue SMS-201-995 on the adrenergic response to glucose ingestion in patients with post prandial hypotension. Am J Med. 1989;1989(86):673\u20137.","journal-title":"Am J Med"},{"issue":"301","key":"473_CR78","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM197907123010202","volume":"1979","author":"AV Chobanian","year":"1979","unstructured":"Chobanian AV, Volicer L, Tifft CP, Gavras H, Liang CS, Faxon D. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N Engl J Med. 1979;1979(301):68\u201373.","journal-title":"N Engl J Med"},{"issue":"24","key":"473_CR79","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2337\/diab.24.4.381","volume":"1975","author":"IW Campbell","year":"1975","unstructured":"Campbell IW, Ewing DJ, Clarke BF. 9-a-fluorohydrocortisone in the treatment of postural hypotension in diabetic autonomic neuropathy. Diabetes. 1975;1975(24):381\u20134.","journal-title":"Diabetes"},{"issue":"32","key":"473_CR80","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/archneur.1975.00490430072013","volume":"1975","author":"MM Hoehn","year":"1975","unstructured":"Hoehn MM. Levodopa-induced postural hypotension. Treatment with fludrocortisone. Arch Neurol. 1975;1975(32):50\u20131.","journal-title":"Arch Neurol."},{"issue":"6014","key":"473_CR81","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/bmj.1.6014.872","volume":"1","author":"IW Campbell","year":"1976","unstructured":"Campbell IW, Ewing DJ, Clarke BF. Therapeutic experience with fludrocortisone in diabetic postural hypotension. Br Med J. 1976;1(6014):872\u20134.","journal-title":"Br Med J."},{"issue":"6","key":"473_CR82","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/hrt.76.6.507","volume":"76","author":"RM Hussain","year":"1996","unstructured":"Hussain RM, McIntosh SJ, Lawson J, Kenny RA. Fludrocortisone in the treatment of hypotensive disorders in the elderly. Heart. 1996;76(6):507\u20139.","journal-title":"Heart."},{"issue":"5\u20136","key":"473_CR83","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00228-005-0941-6","volume":"61","author":"A Pathak","year":"2005","unstructured":"Pathak A, Raoul V, Montastruc JL, Senard JM. Adverse drug reactions related to drugs used in orthostatic hypotension: a prospective and systematic pharmacovigilance study in France. Eur J Clin Pharmacol. 2005;61(5\u20136):471\u20134.","journal-title":"Eur J Clin Pharmacol."},{"issue":"6","key":"473_CR84","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10286-004-0220-0","volume":"14","author":"S Maule","year":"2004","unstructured":"Maule S, Tredici M, Dematteis A, Matteoda C, Chiandussi L. Postprandial hypotension treated with acarbose in a patient with type 1 diabetes mellitus. Clin Auton Res. 2004;14(6):405\u20137.","journal-title":"Clin Auton Res"},{"issue":"2\u20133","key":"473_CR85","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000199185","volume":"31","author":"TJ Lyons","year":"1985","unstructured":"Lyons TJ, McLoughlin JC, Shaw C, Buchanan KD. Effect of acarbose on biochemical responses and clinical symptoms in dumping syndrome. Digestion. 1985;31(2\u20133):89\u201396.","journal-title":"Digestion."},{"issue":"1","key":"473_CR86","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/HYPERTENSIONAHA.107.091355","volume":"50","author":"C Shibao","year":"2007","unstructured":"Shibao C, Gamboa A, Diedrich A, Dossett C, Choi L, Farley G, et al. Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. Hypertension. 2007;50(1):54\u201361.","journal-title":"Hypertension."},{"issue":"2","key":"473_CR87","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0733-8651(01)00005-4","volume":"20","author":"I Biaggioni","year":"2002","unstructured":"Biaggioni I, Robertson RM. Hypertension in orthostatic hypotension and autonomic dysfunction. Cardiol Clin. 2002;20(2):291\u2013301.","journal-title":"Cardiol Clin."},{"issue":"5","key":"473_CR88","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MNH.0b013e328356c52f","volume":"21","author":"AC Arnold","year":"2012","unstructured":"Arnold AC, Biaggioni I. Management approaches to hypertension in autonomic failure. Curr Opin Nephrol Hypertens. 2012;21(5):481\u20135.","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"9205","key":"473_CR89","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(99)05320-9","volume":"355","author":"TD Vagaonescu","year":"2000","unstructured":"Vagaonescu TD, Saadia D, Tuhrim S, Phillips RA, Kaufmann H. Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet. 2000;355(9205):725\u20136.","journal-title":"Lancet."},{"issue":"5","key":"473_CR90","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/HYPERTENSIONAHA.109.136853","volume":"54","author":"EM Garland","year":"2009","unstructured":"Garland EM, Gamboa A, Okamoto L, Raj SR, Black BK, Davis TL, et al. Renal impairment of pure autonomic failure. Hypertension. 2009;54(5):1057\u201361.","journal-title":"Hypertension"},{"issue":"23","key":"473_CR91","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1161\/01.CIR.101.23.2710","volume":"101","author":"JR Shannon","year":"2000","unstructured":"Shannon JR, Jordan J, Diedrich A, Pohar B, Black BK, Robertson D, et al. Sympathetically mediated hypertension in autonomic failure. Circulation. 2000;101(23):2710\u20135.","journal-title":"Circulation."},{"issue":"34","key":"473_CR92","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0002-9149(74)90029-0","volume":"1974","author":"MM Ibrahim","year":"1974","unstructured":"Ibrahim MM, Tarazi RC, Dustan HP, Bravo EL. Idiopathic orthostatic hypotension: circulatory dynamics in chronic autonomic insufficiency. Am J Cardiol. 1974;1974(34):288\u201394.","journal-title":"Am J Cardiol"},{"issue":"76","key":"473_CR93","first-page":"580","volume":"1993","author":"I Biaggioni","year":"1993","unstructured":"Biaggioni I, Garcia F, Inagami T, Haile V. Hyporeninemic normoaldosteronism in severe autonomic failure. J Clin Endocrinol Metab. 1993;1993(76):580\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"473_CR94","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1161\/HYPERTENSIONAHA.107.105171","volume":"51","author":"A Gamboa","year":"2008","unstructured":"Gamboa A, Shibao C, Diedrich A, Paranjape SY, Farley G, Christman B, et al. Excessive nitric oxide function and blood pressure regulation in patients with autonomic failure. Hypertension. 2008;51(6):1531\u20136.","journal-title":"Hypertension"},{"issue":"3","key":"473_CR95","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/HYPERTENSIONAHA.111.00377","volume":"61","author":"AC Arnold","year":"2013","unstructured":"Arnold AC, Okamoto LE, Gamboa A, Shibao C, Raj SR, Robertson D, et al. Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure. Hypertension. 2013;61(3):701\u20136.","journal-title":"Hypertension"},{"issue":"2","key":"473_CR96","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.115.06617","volume":"67","author":"AC Arnold","year":"2016","unstructured":"Arnold AC, Okamoto LE, Gamboa A, Black BK, Raj SR, Elijovich F, et al. Mineralocorticoid receptor activation contributes to the supine hypertension of autonomic failure. Hypertension. 2016;67(2):424\u20139.","journal-title":"Hypertension"},{"issue":"2","key":"473_CR97","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/HYPERTENSIONAHA.108.124552","volume":"53","author":"LE Okamoto","year":"2009","unstructured":"Okamoto LE, Gamboa A, Shibao C, Black BK, Diedrich A, Raj SR, et al. Nocturnal blood pressure dipping in the hypertension of autonomic failure. Hypertension. 2009;53(2):363\u20139.","journal-title":"Hypertension"},{"issue":"Suppl 1","key":"473_CR98","first-page":"A022-A","volume":"68","author":"LE Okamoto","year":"2016","unstructured":"Okamoto LE, Celedonio JE, Gamboa A, Shibao CA, Raj SR, Diedrich A, et al. Abstract 022: Blood pressure-lowering effect of local passive heat in autonomic failure patients with supine hypertension. Hypertension. 2016;68(Suppl 1):A022-A.","journal-title":"Hypertension."},{"issue":"1","key":"473_CR99","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1681\/ASN.V10135","volume":"10","author":"J Jordan","year":"1999","unstructured":"Jordan J, Shannon JR, Pohar B, Paranjape SY, Robertson D, Robertson RM, et al. Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. J Am Soc Nephrol. 1999;10(1):35\u201342.","journal-title":"J Am Soc Nephrol."},{"issue":"11","key":"473_CR100","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1532-5415.1995.tb07393.x","volume":"43","author":"M Pahor","year":"1995","unstructured":"Pahor M, Guralnik JM, Corti MC, Foley DJ, Carbonin P, Havlik RJ. Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc. 1995;43(11):1191\u20137.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"473_CR101","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1161\/HYPERTENSIONAHA.114.04116","volume":"64","author":"LE Okamoto","year":"2014","unstructured":"Okamoto LE, Gamboa A, Shibao CA, Arnold AC, Choi L, Black BK, et al. Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension. Hypertension. 2014;64(6):1241\u20137.","journal-title":"Hypertension"},{"issue":"10","key":"473_CR102","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.jhh.1001735","volume":"18","author":"H Moriwaki","year":"2004","unstructured":"Moriwaki H, Uno H, Nagakane Y, Hayashida K, Miyashita K, Naritomi H. Losartan, an angiotensin II (AT1) receptor antagonist, preserves cerebral blood flow in hypertensive patients with a history of stroke. J Hum Hypertens. 2004;18(10):693\u20139.","journal-title":"J Hum Hypertens"},{"issue":"5","key":"473_CR103","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/01.HYP.0000163460.07639.3f","volume":"45","author":"K Kario","year":"2005","unstructured":"Kario K, Ishikawa J, Hoshide S, Matsui Y, Morinari M, Eguchi K, et al. Diabetic brain damage in hypertension: role of renin-angiotensin system. Hypertension. 2005;45(5):887\u201393.","journal-title":"Hypertension"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-017-0473-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-017-0473-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-017-0473-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T01:36:58Z","timestamp":1719538618000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-017-0473-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,26]]},"references-count":103,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["473"],"URL":"https:\/\/doi.org\/10.1007\/s40263-017-0473-5","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"type":"print","value":"1172-7047"},{"type":"electronic","value":"1179-1934"}],"subject":[],"published":{"date-parts":[[2017,10,26]]}}}